Nayzilam FDA Approval History
Last updated by Judith Stewart, BPharm on Nov 29, 2019.
FDA Approved: Yes (First approved May 17, 2019)
Brand name: Nayzilam
Generic name: midazolam
Dosage form: Nasal Spray
Company: UCB, Inc.
Treatment for: Seizure Clusters
Nayzilam (midazolam) is a nasally administered benzodiazepine indicated for the acute treatment of seizure clusters.
Development timeline for Nayzilam
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.